한글목차

전 세계 화학, 생물, 방사선, 핵(CBRN) 방어 시장 규모는 2035년까지 연평균 5.5%의 성장률을 보일 것으로 예상됩니다.

CBRN 위협 증가, 지정학적 긴장, 통합 방어 시스템, 소형화 탐지, AI 기반 무인 시스템 등이 시장 성장을 촉진하고 있습니다.

실시간 모바일 위협 탐지에 대한 요구가 증가하면서 CBRN 탐지 기술의 비약적인 발전을 촉진하고 있습니다. 센서의 소형화, AI 기반 분석, 자율 모니터링의 혁신은 운영의 유연성을 높이는 소형의 고감도 탐지 장비의 개발을 가능하게 하고 있습니다. 예를 들어, 2025년 6월 화학, 생물, 방사선, 핵 방어 합동계획실행국(JPEO-CBRND)은 스미스 디텍션(Smith Detection)과 공동으로 에어로졸 증기 화학물질 검출기(AVCAD)를 발표했습니다. 이 첨단 시스템은 기존 및 신흥 화학제품을 포함한 증기 및 에어로졸 위협을 자율적으로 감지하고 식별하며, 함정 및 군용 차량과 같은 플랫폼에 원활하게 통합됩니다.

세계의 화학, 생물, 방사선, 핵(CBRN) 방어 시장을 조사했으며, 시장 개요, 시장 성장 촉진요인 및 시장 기회 분석, 시장 규모 추정과 예측, 각종 부문별·지역별·주요 국가별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 보고서 개요

제2장 주요 요약

제3장 시장 개요

• 주요 조사 결과
• 시장 역학
• 영향 분석
  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
• Porter's Five Forces 분석
• PEST 분석

제4장 화학, 생물, 방사선, 핵(CBRN) 방어 시장 분석 : 최종사용자별

• 주요 조사 결과
• 시장 매력도 지수
• 시장 규모 추정과 예측
• 군대
• 국토안보부
  • 시장 규모 추정과 예측 : 지역별
  • 시장 점유율 : 지역별

제5장 화학, 생물, 방사선, 핵(CBRN) 방어 시장 분석 : 유형별

• 주요 조사 결과
• 시장 매력도 지수
• 시장 규모 추정과 예측
• CBRN 제염 시스템
• CBRN 검출 시스템
• CBRN 방호 장비
  • 시장 규모 추정과 예측 : 지역별
  • 시장 점유율 : 지역별

제6장 화학, 생물, 방사선, 핵(CBRN) 방어 시장 분석 : 제염 시스템별

• 주요 조사 결과
• 시장 매력도 지수
• 시장 규모 추정과 예측
• 휴대용 제염 시스템
• 고정형 제염 시설
• 제염제와 제염 용액
• 기타
  • 시장 규모 추정과 예측 : 지역별
  • 시장 점유율 : 지역별

제7장 화학, 생물, 방사선, 핵(CBRN) 방어 시장 분석 : 검출 시스템별

• 주요 조사 결과
• 시장 매력도 지수
• 시장 규모 추정과 예측
• 화학제품 검출 시스템
• 생물 검출 시스템
• 방사선 검출 시스템
• 핵 탐지 시스템
• 기타
  • 시장 규모 추정과 예측 : 지역별
  • 시장 점유율 : 지역별

제8장 화학, 생물, 방사선, 핵(CBRN) 방어 시장 분석 : 방호 장비별

• 주요 조사 결과
• 시장 매력도 지수
• 시장 규모 추정과 예측
• 방독면·호흡기
• 화학 방호복
• 생물 방호복
• 방사선 차폐
• 제염 장비
• 기타
  • 시장 규모 추정과 예측 : 지역별
  • 시장 점유율 : 지역별

제9장 화학, 생물, 방사선, 핵(CBRN) 방어 시장 분석 : 지역별

• 주요 조사 결과
• 시장 규모 추정과 예측

제10장 북미의 화학, 생물, 방사선, 핵(CBRN) 방어 시장 분석

제11장 유럽의 화학, 생물, 방사선, 핵(CBRN) 방어 시장 분석

제12장 아시아태평양의 화학, 생물, 방사선, 핵(CBRN) 방어 시장 분석

제13장 라틴아메리카의 화학, 생물, 방사선, 핵(CBRN) 방어 시장 분석

제14장 중동 및 아프리카의 화학, 생물, 방사선, 핵(CBRN) 방어 시장 분석

제15장 기업 개요

• 경쟁 구도
• 전략적 전망
• Northrop Grumman Corporation
• Lockheed Martin Corporation
• Textron Inc.
• Elbit Systems Ltd.
• Rheinmetall AG
• Honeywell International Inc.
• Teledyne FLIR LLC
• Thermo Fisher Scientific Inc.
• Smiths Group plc
• The Chemours Company
• Argon Electronics(UK) Ltd.
• Environics Oy
• Bruker Corporation
• Blucher GmbH
• Chemring Group PLC
• Thales Group
• SaaB AB
• Battelle
• Indra Sistemas
• Leidos

제16장 결론과 제안

• Visiongain에 의한 결론
• 진출 기업에 대한 제안

영문목차

The global Chemical, Biological, Radiological & Nuclear (CBRN) Defence market is projected to grow at a CAGR of 5.5% by 2035.

The Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Report 2025-2035: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Rising CBRN Threats, Geopolitical Tensions, Integrated Defence Systems, Miniaturised Detection, and AI-driven Unmanned Systems are Driving Market Growth

The growing need for real-time, mobile threat detection is driving breakthroughs in CBRN detection technology. Innovations in sensor miniaturisation, AI-driven analytics, and autonomous monitoring are enabling the development of compact, highly sensitive detection devices that enhance operational flexibility. For instance, in June 2025, the Joint Programme Executive Office for Chemical, Biological, Radiological, and Nuclear Defence (JPEO-CBRND), in collaboration with Smiths Detection, introduced the Aerosol Vapor Chemical Agent Detector (AVCAD). This advanced system autonomously detects and identifies vapour and aerosol threats, including both conventional and emerging chemical agents, while offering seamless integration across platforms such as naval vessels and military vehicles.

Similarly, in July 2023, Draper introduced CBRN hazard detection capabilities for small unmanned aerial vehicles (sUAVs). These drones, equipped with miniaturised sensors, enable military forces to remotely assess hazardous environments, reducing personnel exposure. Such innovations are transforming military and emergency response operations, providing instant situational awareness and enhancing safety for defence forces, first responders, and industrial security teams.

High Costs, Budget Constraints, Logistical Challenges, and Market Saturation in Developed Nations are Limiting Industry Growth Opportunities

Developing and maintaining CBRN defence capabilities requires significant financial investment, with high costs associated with advanced detection systems, decontamination units, and protective equipment. For instance, India's National Disaster Response Force (NDRF) inducted four Hazardous Material (Hazmat) vehicles in August 2023, each costing ,Cπ15 crore (~$8 million), highlighting the financial burden of such capabilities. Budget constraints further hinder adoption, as governments prioritise conventional defence over specialised CBRN preparedness, delaying investments in next-generation countermeasures.

Additionally, mature defence markets in developed nations limit expansion opportunities, with procurement cycles focused on system upgrades rather than new acquisitions. Countries like the U.S. and U.K. are emphasising modernisation efforts such as AI-driven threat detection over large-scale new deployments, slowing market growth. In response, companies are shifting towards emerging economies, where CBRN preparedness is still developing. Despite market saturation, competition is driving innovation, pushing firms to develop cost-effective, AI-integrated, and autonomous CBRN solutions to sustain their market position.

What Questions Should You Ask before Buying a Market Research Report?

• How is the chemical, biological, radiological & nuclear (CBRN) defence market evolving?
• What is driving and restraining the chemical, biological, radiological & nuclear (CBRN) defence market?
• How will each chemical, biological, radiological & nuclear (CBRN) defence submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2035?
• How will the market shares for each chemical, biological, radiological & nuclear (CBRN) defence submarket develop from 2025 to 2035?
• What will be the main driver for the overall market from 2025 to 2035?
• Will leading chemical, biological, radiological & nuclear (CBRN) defence markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2035 and which geographical region will lead the market in 2035?
• Who are the leading players and what are their prospects over the forecast period?
• What are the chemical, biological, radiological & nuclear (CBRN) defence projects for these leading companies?
• How will the industry evolve during the period between 2025 and 2035? What are the implications of chemical, biological, radiological & nuclear (CBRN) defence projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the chemical, biological, radiological & nuclear (CBRN) defence market?
• Where is the chemical, biological, radiological & nuclear (CBRN) defence market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the chemical, biological, radiological & nuclear (CBRN) defence market today, and over the next 10 years:

• Our 370-page report provides 138 tables and 220 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them - NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.
• Forecasts to 2035 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2035, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising chemical, biological, radiological & nuclear (CBRN) defence prices and recent developments.

Segments Covered in the Report

• End-users
• Military Forces
• Homeland Security Forces
• Type
• CBRN Decontamination Systems
• CBRN Detection Systems
• CBRN Protection Equipment
• Decontamination Systems
• Portable Decontamination Systems
• Fixed Decontamination Systems
• Decontamination Agents and Solutions
• Other Decontamination Systems
• Detection Systems
• Chemical Detection Systems
• Biological Detection Systems
• Radiological Detection Systems
• Nuclear Detection Systems
• Other Detection Systems
• Protection Equipment
• Gas Masks and Respirators
• Chemical Protective Suits
• Biological Protective Suits
• Radiation Shielding
• Decontamination Equipment
• Other Protection Equipment

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 16 leading national markets:

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Rest of Asia-Pacific
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• MEA
• GCC
• South Africa
• Rest of MEA

The report also includes profiles and for some of the leading companies in the Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market, 2025 to 2035, with a focus on this segment of these companies' operations.

• Leading companies profiled in the report
• Argon Electronics (UK) Ltd
• Battelle
• Blucher GmbH
• Bruker Corporation
• Chemring Group
• Elbit Systems Ltd
• Environics Oy
• Honeywell International Inc
• Indra Sistemas
• Leidos
• Lockheed Martin Corporation
• Northrop Grumman Corporation
• Rheinmetall AG
• SaaB AB
• Smith's Group plc
• Teledyne FLIR LLC
• Textron Inc.
• Thales Group
• The Chemours Company
• Thermo Fisher Scientific Inc.

Overall world revenue for Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market, 2025 to 2035 in terms of value the market will surpass US$20 billion in 2025, our work calculates. We predict strong revenue growth through to 2035. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

• How will the Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market, 2025 to 2035 report help you?
• In summary, our 370-page report provides you with the following knowledge:
• Revenue forecasts to 2035 for Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market, 2025 to 2035 Market, with forecasts for end-users, type, decontamination systems, detection systems, and protection equipment, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2035 for five regional and 16 key national markets - See forecasts for the Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market, 2025 to 2035 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market - including company profiles for 20 of the major companies involved in the Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market, 2025 to 2035.
• Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Table of Contents

1 Report Overview

• 1.1 Objectives of the Study
• 1.2 Introduction to Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market
• 1.3 What This Report Delivers
• 1.4 Why You Should Read This Report
• 1.5 Key Questions Answered by This Analytical Report
• 1.6 Who is This Report for?
• 1.7 Methodology
  • 1.7.1 Market Definitions
  • 1.7.2 Market Evaluation & Forecasting Methodology
  • 1.7.3 Data Validation
    • 1.7.3.1 Primary Research
    • 1.7.3.2 Secondary Research
• 1.8 Frequently Asked Questions (FAQs)
• 1.9 Associated Visiongain Reports
• 1.10 About Visiongain

2 Executive Summary

3 Market Overview

• 3.1 Key Findings
• 3.2 Market Dynamics
• 3.3 Impact Analysis
  • 3.3.1 Market Driving Factors
    • 3.3.1.1 Increasing Threat of CBRN Incidents Necessitating Advanced Protective Measures
    • 3.3.1.2 Impact of Rising Geopolitical Tensions on the CBRN Defence Industry
    • 3.3.1.3 Increasing Adoption of Integrated CBRN Defence Systems
    • 3.3.1.4 Technological Innovations Drive Miniaturization of CBRN Detection and Monitoring Devices
    • 3.3.1.5 Rapid Expansion of Unmanned Systems for CBRN Defence, Driven by AI, Robotics, and Autonomous Technologies
  • 3.3.2 Market Restraining Factors
    • 3.3.2.1 High Costs and Budget Constraints
    • 3.3.2.2 Logistical and Deployment Challenges
    • 3.3.2.3 Evolving and Unpredictable Threat Landscape
    • 3.3.2.4 Market Maturity in Developed Nations Limits Expansion Opportunities
  • 3.3.3 Market Opportunities
    • 3.3.3.1 Expansion of Simulated Training Environments Presents Growth Opportunities in CBRN Defence
    • 3.3.3.2 Global Surge in Government Spending on CBRN Defence Solutions Drives Market Growth
    • 3.3.3.3 Integrating CBRN Detection into Smart City Infrastructure
• 3.4 Porter's Five Forces Analysis
  • 3.4.1 Bargaining Power of Suppliers
  • 3.4.2 Bargaining Power of Buyers
  • 3.4.3 Competitive Rivalry
  • 3.4.4 Threat of Substitutes
  • 3.4.5 Threat of New Entrants
• 3.5 PEST Analysis

4 Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Analysis by End-users

• 4.1 Key Findings
• 4.2 End-users Segment: Market Attractiveness Index
• 4.3 Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Size Estimation and Forecast by End-users
• 4.4 Military Forces
  • 4.4.1 Market Size by Region, 2025-2035 (US$ Million)
  • 4.4.2 Market Share by Region, 2025 & 2035 (%)
• 4.5 Homeland Security Forces
  • 4.5.1 Market Size by Region, 2025-2035 (US$ Million)
  • 4.5.2 Market Share by Region, 2025 & 2035 (%)

5 Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Analysis by Type

• 5.1 Key Findings
• 5.2 Type Segment: Market Attractiveness Index
• 5.3 Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Size Estimation and Forecast by Type
• 5.4 CBRN Decontamination Systems
  • 5.4.1 Market Size by Region, 2025-2035 (US$ Million)
  • 5.4.2 Market Share by Region, 2025 & 2035 (%)
• 5.5 CBRN Detection Systems
  • 5.5.1 Market Size by Region, 2025-2035 (US$ Million)
  • 5.5.2 Market Share by Region, 2025 & 2035 (%)
• 5.6 CBRN Protection Equipment
  • 5.6.1 Market Size by Region, 2025-2035 (US$ Million)
  • 5.6.2 Market Share by Region, 2025 & 2035 (%)

6 Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Analysis by Decontamination Systems

• 6.1 Key Findings
• 6.2 Decontamination Systems Segment: Market Attractiveness Index
• 6.3 Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Size Estimation and Forecast by Decontamination Systems
• 6.4 Portable Decontamination Systems
  • 6.4.1 Market Size by Region, 2025-2035 (US$ Million)
  • 6.4.2 Market Share by Region, 2025 & 2035 (%)
• 6.5 Fixed Decontamination Facilities
  • 6.5.1 Market Size by Region, 2025-2035 (US$ Million)
  • 6.5.2 Market Share by Region, 2025 & 2035 (%)
• 6.6 Decontamination Agents and Solutions
  • 6.6.1 Market Size by Region, 2025-2035 (US$ Million)
  • 6.6.2 Market Share by Region, 2025 & 2035 (%)
• 6.7 Other Decontamination Systems
  • 6.7.1 Market Size by Region, 2025-2035 (US$ Million)
  • 6.7.2 Market Share by Region, 2025 & 2035 (%)

7 Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Analysis by Detection Systems

• 7.1 Key Findings
• 7.2 Detection Systems Segment: Market Attractiveness Index
• 7.3 Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Size Estimation and Forecast by Detection Systems
• 7.4 Chemical Detection Systems
  • 7.4.1 Market Size by Region, 2025-2035 (US$ Million)
  • 7.4.2 Market Share by Region, 2025 & 2035 (%)
• 7.5 Biological Detection Systems
  • 7.5.1 Market Size by Region, 2025-2035 (US$ Million)
  • 7.5.2 Market Share by Region, 2025 & 2035 (%)
• 7.6 Radiological Detection Systems
  • 7.6.1 Market Size by Region, 2025-2035 (US$ Million)
  • 7.6.2 Market Share by Region, 2025 & 2035 (%)
• 7.7 Nuclear Detection Systems
  • 7.7.1 Market Size by Region, 2025-2035 (US$ Million)
  • 7.7.2 Market Share by Region, 2025 & 2035 (%)
• 7.8 Other Detection Systems
  • 7.8.1 Market Size by Region, 2025-2035 (US$ Million)
  • 7.8.2 Market Share by Region, 2025 & 2035 (%)

8 Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Analysis by Protection Equipment

• 8.1 Key Findings
• 8.2 Protection Equipment Segment: Market Attractiveness Index
• 8.3 Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Size Estimation and Forecast by Protection Equipment
• 8.4 Gas Masks and Respirators
  • 8.4.1 Market Size by Region, 2025-2035 (US$ Million)
  • 8.4.2 Market Share by Region, 2025 & 2035 (%)
• 8.5 Chemical Protective Suits
  • 8.5.1 Market Size by Region, 2025-2035 (US$ Million)
  • 8.5.2 Market Share by Region, 2025 & 2035 (%)
• 8.6 Biological Protective Suits
  • 8.6.1 Market Size by Region, 2025-2035 (US$ Million)
  • 8.6.2 Market Share by Region, 2025 & 2035 (%)
• 8.7 Radiation Shielding
  • 8.7.1 Market Size by Region, 2025-2035 (US$ Million)
  • 8.7.2 Market Share by Region, 2025 & 2035 (%)
• 8.8 Decontamination Equipment
  • 8.8.1 Market Size by Region, 2025-2035 (US$ Million)
  • 8.8.2 Market Share by Region, 2025 & 2035 (%)
• 8.9 Other Protection Equipment
  • 8.9.1 Market Size by Region, 2025-2035 (US$ Million)
  • 8.9.2 Market Share by Region, 2025 & 2035 (%)

9 Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Analysis by Region

• 9.1 Key Findings
• 9.2 Regional Market Size Estimation and Forecast

10 North America Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Analysis

• 10.1 Key Findings
• 10.2 North America Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Attractiveness Index
• 10.3 North America Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market by Country, 2025, 2030 & 2035 (US$ Million)
• 10.4 North America Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Size Estimation and Forecast by Country
• 10.5 North America Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Size Estimation and Forecast by End-Use
• 10.6 North America Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Size Estimation and Forecast by Type
• 10.7 North America Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Size Estimation and Forecast by Decontamination Systems
• 10.8 North America Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Size Estimation and Forecast by Detection Systems
• 10.9 North America Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Size Estimation and Forecast by Protection Equipment
• 10.10 U.S. Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Analysis
• 10.11 Canada Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Analysis

11 Europe Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Analysis

• 11.1 Key Findings
• 11.2 Europe Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Attractiveness Index
• 11.3 Europe Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market by Country, 2025, 2030 & 2035 (US$ Million)
• 11.4 Europe Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Size Estimation and Forecast by Country
• 11.5 Europe Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Size Estimation and Forecast by End-Use
• 11.6 Europe Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Size Estimation and Forecast by Type
• 11.7 Europe Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Size Estimation and Forecast by Decontamination Systems
• 11.8 Europe Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Size Estimation and Forecast by Detection Systems
• 11.9 Europe Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Size Estimation and Forecast by Protection Equipment
• 11.10 Germany Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Analysis
• 11.11 UK Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Analysis
• 11.12 France Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Analysis
• 11.13 Italy Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Analysis
• 11.14 Russia Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Analysis
• 11.15 Rest of Europe Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Analysis

12 Asia Pacific Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Analysis

• 12.1 Key Findings
• 12.2 Asia Pacific Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Attractiveness Index
• 12.3 Asia Pacific Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market by Country, 2025, 2030 & 2035 (US$ Million)
• 12.4 Asia Pacific Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Size Estimation and Forecast by Country
• 12.5 Asia Pacific Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Size Estimation and Forecast by End-Use
• 12.6 Asia Pacific Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Size Estimation and Forecast by Type
• 12.7 Asia Pacific Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Size Estimation and Forecast by Decontamination Systems
• 12.8 Asia Pacific Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Size Estimation and Forecast by Detection Systems
• 12.9 Asia Pacific Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Size Estimation and Forecast by Protection Equipment
• 12.10 Japan Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Analysis
• 12.11 China Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Analysis
• 12.12 India Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Analysis
• 12.13 Australia Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Analysis
• 12.14 South Korea Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Analysis
• 12.15 Rest of Asia Pacific Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Analysis

13 Latin America Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Analysis

• 13.1 Key Findings
• 13.2 Latin America Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Attractiveness Index
• 13.3 Latin America Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market by Country, 2025, 2030 & 2035 (US$ Million)
• 13.4 Latin America Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Size Estimation and Forecast by Country
• 13.5 Latin America Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Size Estimation and Forecast by End-Use
• 13.6 Latin America Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Size Estimation and Forecast by Type
• 13.7 Latin America Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Size Estimation and Forecast by Decontamination Systems
• 13.8 Latin America Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Size Estimation and Forecast by Detection Systems
• 13.9 Latin America Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Size Estimation and Forecast by Protection Equipment
• 13.10 Brazil Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Analysis
• 13.11 Mexico Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Analysis
• 13.12 Rest of Latin America Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Analysis

14 MEA Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Analysis

• 14.1 Key Findings
• 14.2 MEA Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Attractiveness Index
• 14.3 MEA Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market by Country, 2025, 2030 & 2035 (US$ Million)
• 14.4 MEA Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Size Estimation and Forecast by Country
• 14.5 MEA Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Size Estimation and Forecast by End-Use
• 14.6 MEA Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Size Estimation and Forecast by Type
• 14.7 MEA Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Size Estimation and Forecast by Decontamination Systems
• 14.8 MEA Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Size Estimation and Forecast by Detection Systems
• 14.9 MEA Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Size Estimation and Forecast by Protection Equipment
• 14.10 GCC Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Analysis
• 14.11 South Africa Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Analysis
• 14.12 Rest of MEA Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Analysis

15 Company Profiles

• 15.1 Competitive Landscape, 2023
• 15.2 Strategic Outlook
• 15.3 Northrop Grumman Corporation
  • 15.3.1 Company Snapshot
  • 15.3.2 Company Overview
  • 15.3.3 Financial Analysis
    • 15.3.3.1 Net Revenue, 2019-2023
    • 15.3.3.2 R&D, 2019-2023
    • 15.3.3.3 Regional Market Shares, 2023
    • 15.3.3.4 Business Segment Market Shares, 2023
  • 15.3.4 Product Benchmarking
  • 15.3.5 Strategic Outlook
  • 15.3.6 SWOT Analysis
• 15.4 Lockheed Martin Corporation
  • 15.4.1 Company Snapshot
  • 15.4.2 Company Overview
  • 15.4.3 Financial Analysis
    • 15.4.3.1 Net Revenue, 2019-2023
    • 15.4.3.2 R&D, 2019-2023
    • 15.4.3.3 Regional Market Shares, 2023
    • 15.4.3.4 Business Segment Market Shares, 2023
  • 15.4.4 Product Benchmarking
  • 15.4.5 Strategic Outlook
  • 15.4.6 SWOT Analysis
• 15.5 Textron Inc.
  • 15.5.1 Company Snapshot
  • 15.5.2 Company Overview
  • 15.5.3 Financial Analysis
    • 15.5.3.1 Net Revenue, 2019-2023
    • 15.5.3.2 R&D, 2019-2023
    • 15.5.3.3 Regional Market Shares, 2023
    • 15.5.3.4 Business Segment Market Shares, 2023
  • 15.5.4 Product Benchmarking
  • 15.5.5 Strategic Outlook
• 15.6 Elbit Systems Ltd.
  • 15.6.1 Company Snapshot
  • 15.6.2 Company Overview
  • 15.6.3 Financial Analysis
    • 15.6.3.1 Net Revenue, 2019-2023
    • 15.6.3.2 R&D, 2019-2023
    • 15.6.3.3 Regional Market Shares, 2023
    • 15.6.3.4 Business Segment Market Shares, 2023
  • 15.6.4 Product Benchmarking
  • 15.6.5 Strategic Outlook
• 15.7 Rheinmetall AG
  • 15.7.1 Company Snapshot
  • 15.7.2 Company Overview
  • 15.7.3 Financial Analysis
    • 15.7.3.1 Net Revenue, 2019-2023
    • 15.7.3.2 R&D, 2019-2023
    • 15.7.3.3 Regional Market Shares, 2023
    • 15.7.3.4 Business Segment Market Shares, 2023
  • 15.7.4 Product Benchmarking
  • 15.7.5 Strategic Outlook
• 15.8 Honeywell International Inc.
  • 15.8.1 Company Snapshot
  • 15.8.2 Company Overview
  • 15.8.3 Financial Analysis
    • 15.8.3.1 Net Revenue, 2019-2023
    • 15.8.3.2 R&D, 2019-2023
    • 15.8.3.3 Regional Market Shares, 2023
    • 15.8.3.4 Business Segment Market Shares, 2023
  • 15.8.4 Product Benchmarking
  • 15.8.5 Strategic Outlook
• 15.9 Teledyne FLIR LLC
  • 15.9.1 Company Snapshot
  • 15.9.2 Company Overview
  • 15.9.3 Financial Analysis
    • 15.9.3.1 Net Revenue, 2019-2023
    • 15.9.3.2 R&D, 2019-2023
    • 15.9.3.3 Regional Market Shares, 2023
    • 15.9.3.4 Business Segment Market Shares, 2023
  • 15.9.4 Product Benchmarking
  • 15.9.5 Strategic Outlook
• 15.10 Thermo Fisher Scientific Inc.
  • 15.10.1 Company Snapshot
  • 15.10.2 Company Overview
  • 15.10.3 Financial Analysis
    • 15.10.3.1 Net Revenue, 2019-2023
    • 15.10.3.2 R&D, 2019-2023
    • 15.10.3.3 Regional Market Shares, 2023
    • 15.10.3.4 Business Segment Market Shares, 2023
  • 15.10.4 Product Benchmarking
  • 15.10.5 Strategic Outlook
• 15.11 Smiths Group plc
  • 15.11.1 Company Snapshot
  • 15.11.2 Company Overview
  • 15.11.3 Financial Analysis
    • 15.11.3.1 Net Revenue, 2019-2023
    • 15.11.3.2 R&D, 2019-2023
    • 15.11.3.3 Regional Market Shares, 2023
    • 15.11.3.4 Business Segment Market Shares, 2023
  • 15.11.4 Product Benchmarking
  • 15.11.5 Strategic Outlook
• 15.12 The Chemours Company
  • 15.12.1 Company Snapshot
  • 15.12.2 Company Overview
  • 15.12.3 Financial Analysis
    • 15.12.3.1 Net Revenue, 2019-2023
    • 15.12.3.2 R&D, 2019-2023
    • 15.12.3.3 Regional Market Shares, 2023
    • 15.12.3.4 Business Segment Market Shares, 2023
  • 15.12.4 Product Benchmarking
  • 15.12.5 Strategic Outlook
• 15.13 Argon Electronics (UK) Ltd.
  • 15.13.1 Company Snapshot
  • 15.13.2 Company Overview
  • 15.13.3 Product Benchmarking
  • 15.13.4 Strategic Outlook
• 15.14 Environics Oy
  • 15.14.1 Company Snapshot
  • 15.14.2 Company Overview
  • 15.14.3 Financial Analysis
    • 15.14.3.1 Net Revenue, 2019-2023
    • 15.14.3.2 R&D, 2019-2023
    • 15.14.3.3 Business Segment Market Shares, 2023
  • 15.14.4 Product Benchmarking
  • 15.14.5 Strategic Outlook
• 15.15 Bruker Corporation
  • 15.15.1 Company Snapshot
  • 15.15.2 Company Overview
  • 15.15.3 Financial Analysis
    • 15.15.3.1 Net Revenue, 2019-2023
    • 15.15.3.2 R&D, 2019-2023
    • 15.15.3.3 Regional Market Shares, 2023
    • 15.15.3.4 Business Segment Market Shares, 2023
  • 15.15.4 Product Benchmarking
  • 15.15.5 Strategic Outlook
• 15.16 Blucher GmbH
  • 15.16.1 Company Snapshot
  • 15.16.2 Company Overview
  • 15.16.3 Product Benchmarking
  • 15.16.4 Strategic Outlook
• 15.17 Chemring Group PLC
  • 15.17.1 Company Snapshot
  • 15.17.2 Company Overview
  • 15.17.3 Financial Analysis
    • 15.17.3.1 Net Revenue, 2019-2023
    • 15.17.3.2 R&D, 2019-2023
    • 15.17.3.3 Regional Market Shares, 2023
    • 15.17.3.4 Business Segment Market Shares, 2023
  • 15.17.4 Product Benchmarking
  • 15.17.5 Strategic Outlook
• 15.18 Thales Group
  • 15.18.1 Company Snapshot
  • 15.18.2 Company Overview
  • 15.18.3 Financial Analysis
    • 15.18.3.1 Net Revenue, 2019-2023
    • 15.18.3.2 R&D, 2019-2023
    • 15.18.3.3 Regional Market Shares, 2023
    • 15.18.3.4 Business Segment Market Shares, 2023
  • 15.18.4 Product Benchmarking
  • 15.18.5 Strategic Outlook
  • 15.18.6 SWOT Analysis
• 15.19 SaaB AB
  • 15.19.1 Company Snapshot
  • 15.19.2 Company Overview
  • 15.19.3 Financial Analysis
    • 15.19.3.1 Net Revenue, 2019-2023
    • 15.19.3.2 R&D, 2019-2023
    • 15.19.3.3 Regional Market Shares, 2023
    • 15.19.3.4 Business Segment Market Shares, 2023
  • 15.19.4 Product Benchmarking
  • 15.19.5 Strategic Outlook
• 15.20 Battelle
  • 15.20.1 Company Snapshot
  • 15.20.2 Company Overview
  • 15.20.3 Product Benchmarking
  • 15.20.4 Strategic Outlook
• 15.21 Indra Sistemas
  • 15.21.1 Company Snapshot
  • 15.21.2 Company Overview
  • 15.21.3 Financial Analysis
    • 15.21.3.1 Net Revenue, 2019-2023
    • 15.21.3.2 Regional Market Shares, 2023
    • 15.21.3.3 Segment Market Shares, 2023
  • 15.21.4 Product Benchmarking
  • 15.21.5 Strategic Outlook
• 15.22 Leidos
  • 15.22.1 Company Snapshot
  • 15.22.2 Company Overview
  • 15.22.3 Financial Analysis
    • 15.22.3.1 Net Revenue, 2019-2023
    • 15.22.3.2 R&D, 2019-2023
    • 15.22.3.3 Regional Market Shares, 2023
    • 15.22.3.4 Business Segment Market Shares, 2023
  • 15.22.4 Product Benchmarking
  • 15.22.5 Strategic Outlook

16 Conclusion and Recommendations

• 16.1 Concluding Remarks from Visiongain
• 16.2 Recommendations for Market Players